Research Output 1987 2019

Filter
Letter
2019
13 Citations (Scopus)

Hepatocytes direct the formation of a pro-metastatic niche in the liver

Lee, J. W., Stone, M. L., Porrett, P. M., Thomas, S. K., Komar, C. A., Li, J. H., Delman, D., Graham, K., Gladney, W. L., Hua, X., Black, T. A., Chien, A. L., Majmundar, K. S., Thompson, J. C., Yee, S. S., O’Hara, M. H., Aggarwal, C., Xin, D., Shaked, A., Gao, M. & 9 others, Liu, D., Borad, M. J., Ramanathan, R. K., Carpenter, E. L., Ji, A., de Beer, M. C., de Beer, F. C., Webb, N. R. & Beatty, G. L., Mar 14 2019, In : Nature. 567, 7747, p. 249-252 4 p.

Research output: Contribution to journalLetter

Hepatocytes
Liver
STAT3 Transcription Factor
Neoplasm Metastasis
Circulating Neoplastic Cells

KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival

Vendramini, E., Bomben, R., Pozzo, F., Benedetti, D., Bittolo, T., Rossi, F. M., Dal Bo, M., Rabe, K. G., Pozzato, G., Zaja, F., Chiarenza, A., Di Raimondo, F., Braggio, E. D., Parikh, S. A., Kay, N. E., Shanafelt, T. D., Del Poeta, G., Gattei, V. & Zucchetto, A., Jan 1 2019, In : Leukemia.

Research output: Contribution to journalLetter

Open Access
Trisomy
B-Cell Chronic Lymphocytic Leukemia
Mutation

MYC dysregulation in the progression of multiple myeloma

MMRF CoMMpass Network, Jan 1 2019, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalLetter

Multiple Myeloma

Perceived risk for cancer progression and psychological status in chronic lymphocytic leukemia patients: CALGB 70603 (Alliance)

Deshields, T. L., Dueck, A., Rogers, K., Brown, J. R., Shanafelt, T., Mintzer, D. & Byrd, J. C., Jan 1 2019, In : Leukemia and Lymphoma.

Research output: Contribution to journalLetter

B-Cell Chronic Lymphocytic Leukemia
Psychology
Neoplasms
9 Citations (Scopus)

Two-Year Survival Comparing Web-Based Symptom Monitoring vs Routine Surveillance Following Treatment for Lung Cancer

Denis, F., Basch, E., Septans, A. L., Bennouna, J., Urban, T., Dueck, A. & Letellier, C., Jan 22 2019, In : JAMA - Journal of the American Medical Association. 321, 3, p. 306-307 2 p.

Research output: Contribution to journalLetter

Lung Neoplasms
2018

Mutational screening of newly diagnosed multiple myeloma patients by deep targeted sequencing

Ruiz-Heredia, Y., Sánchez-Vega, B., Onecha, E., Barrio, S., Alonso, R., Martínez-Ávila, J. C., Cuenca, I., Agirre, X., Braggio, E. D., Hernández, M. T., Martínez, R., Rosiñol, L., Gutierrez, N., Martin-Ramos, M., Ocio, E. M., Echeveste, M. A., de Oteyza, J. P., Oriol, A., Bargay, J., Gironella, M. & 9 others, Ayala, R., Bladé, J., Mateos, M. V., Kortum, K. M., Stewart, A. K., García-Sanz, R., Miguel, J. S., Lahuerta, J. J. & Martinez-Lopez, J., Nov 1 2018, In : Haematologica. 103, 11, p. e544-e548

Research output: Contribution to journalLetter

High-Throughput Nucleotide Sequencing
Multiple Myeloma
1 Citation (Scopus)

Nivolumab-associated bone marrow necrosis

Hilal, T., Bansal, P., Kelemen, K. & Slack, J. L., Feb 1 2018, In : Annals of Oncology. 29, 2, p. 513-514 2 p.

Research output: Contribution to journalLetter

Osteonecrosis
Bone Marrow
nivolumab
3 Citations (Scopus)

Outcomes of a large cohort of individuals with clinically ascertained high-count monoclonal B-cell lymphocytosis

Parikh, S. A., Chaffee, K. G., Larson, M. C., Hampel, P. J., Call, T. G., Ding, W. D., Kenderian, S., Leis, J. F., Chanan Khan, A. A., Conte, M. J., Bowen, D., Schwager, S. M., Slager, S. L., Hanson, C. A., Kay, N. E. & Shanafelt, T. D., Jun 3 2018, In : Haematologica. 103, 6, p. e237-e240

Research output: Contribution to journalLetter

Lymphocytosis
B-Lymphocytes
2017

Authors' reply to comment What should be the endpoints of a symptomatic drug and its control?

Mesa, R. & Harrison, C., Nov 1 2017, In : The Lancet Haematology. 4, 11, p. e508-e509

Research output: Contribution to journalLetter

Drug and Narcotic Control

Authors' reply to letter to editor: Confusion solved; sort of

Abdel-Misih, S. & Bekaii-Saab, T., Aug 1 2017, In : JNCCN Journal of the National Comprehensive Cancer Network. 15, 8, p. 975-976 2 p.

Research output: Contribution to journalLetter

2 Citations (Scopus)

Correlation between markers of bone metabolism and Vitamin D levels in patients with monoclonal gammopathy of undetermined significance (MGUS)

Lipe, B., Kambhampati, S., Van Veldhuizen, P., Yacoub, A., Aljitawi, O. & Mikhael, J. R., Dec 1 2017, In : Blood Cancer Journal. 7, 12, 646.

Research output: Contribution to journalLetter

Monoclonal Gammopathy of Undetermined Significance
Vitamin D
Bone and Bones
7 Citations (Scopus)

Feasibility study of online yoga for symptom management in patients with myeloproliferative neoplasms

Huberty, J., Eckert, R., Gowin, K., Mitchell, J., Dueck, A., Ginos, B. F., Larkey, L. & Mesa, R., Sep 30 2017, In : Haematologica. 102, 10, p. e384-e388

Research output: Contribution to journalLetter

Yoga
Feasibility Studies
Neoplasms
267 Citations (Scopus)

Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment

Basch, E., Deal, A. M., Dueck, A., Scher, H. I., Kris, M. G., Hudis, C. & Schrag, D., Jul 11 2017, In : JAMA - Journal of the American Medical Association. 318, 2, p. 197-198 2 p.

Research output: Contribution to journalLetter

Neoplasms
Patient Reported Outcome Measures
2 Citations (Scopus)

Patient-reported symptom monitoring during chemotherapy - Reply

Basch, E., Deal, A. M. & Dueck, A., Nov 21 2017, In : JAMA - Journal of the American Medical Association. 318, 19, p. 1935-1936 2 p.

Research output: Contribution to journalLetter

Physiologic Monitoring
Drug Therapy
Neoplasms
1 Citation (Scopus)
Thromboplastin
Thrombosis
Biomarkers
Neoplasms
7 Citations (Scopus)

PKM2 and other key regulators of Warburg effect positively correlate with CD147 (EMMPRIN) gene expression and predict survival in multiple myeloma

Panchabhai, S., Schlam, I., Sebastian, S. & Fonseca, R., Apr 1 2017, In : Leukemia. 31, 4, p. 991-994 4 p.

Research output: Contribution to journalLetter

Multiple Myeloma
Gene Expression

Response to Drs von Hoff and Renschler

Ahn, D. & Bekaii-Saab, T., Jun 1 2017, In : Therapeutic Advances in Medical Oncology. 9, 6, p. 445-446 2 p.

Research output: Contribution to journalLetter

1 Citation (Scopus)

Systolic dysfunction associated with carfilzomib use in patients with multiple myeloma

Jain, T., Narayanasamy, H., Mikhael, J. R., Reeder, C. B., Bergsagel, P. L., Mayo, A., Stewart, A. K., Mookadam, F. & Fonseca, R., Dec 1 2017, In : Blood Cancer Journal. 7, 12, 642.

Research output: Contribution to journalLetter

Multiple Myeloma
carfilzomib
2016

A pharmacogenetic analysis of the Canadian Cancer Trials Group MY.10 clinical trial of maintenance therapy for multiple myeloma

Han, M., Murugesan, A., Bahlis, N. J., Song, K., White, D., Chen, C., Seftel, M. D., Howsen-Jan, K., Reece, D., Stewart, A. K., Xie, Y., Hay, A. E., Shepherd, L., Djurfeldt, M., Zhu, L., Meyer, R. M., Chen, B. E. & Reiman, T., Aug 4 2016, In : Blood. 128, 5, p. 732-735 4 p.

Research output: Contribution to journalLetter

9 Citations (Scopus)

A phase Ib study of the combination of the aurora kinase inhibitor alisertib (MLN8237) and bortezomib in relapsed multiple myeloma

Rosenthal, A., Kumar, S. K., Hofmeister, C., Laubach, J., Vij, R., Dueck, A., Gano, K. & Stewart, A. K., Jul 1 2016, In : British Journal of Haematology. 174, 2, p. 323-325 3 p.

Research output: Contribution to journalLetter

Aurora Kinases
Multiple Myeloma
Recurrence
MLN 8237
Bortezomib
12 Citations (Scopus)

Discrepancies of applying primary myelofibrosis prognostic scores for patients with post polycythemia vera/essential thrombocytosis myelofibrosis

Gowin, K., Coakley, M., Kosiorek, H. & Mesa, R., Sep 30 2016, In : Haematologica. 101, 10, p. e405-e406

Research output: Contribution to journalLetter

Thrombocytosis
Polycythemia Vera
Primary Myelofibrosis

In reply

Scherber, R. M. & Mesa, R. A., Sep 13 2016, In : JAMA - Journal of the American Medical Association. 316, 10, p. 1115 1 p.

Research output: Contribution to journalLetter

2 Citations (Scopus)

Phase II trial of nab-paclitaxel in patients with relapsed or refractory multiple myeloma

Jain, T., Dueck, A., Kosiorek, H. E., Ginos, B. F., Mayo, A., Reeder, C. B., Chesi, M., Mikhael, J. R., Stewart, A. K., Bergsagel, P. L. & Fonseca, R., Dec 1 2016, In : American Journal of Hematology. 91, 12, p. E504-E505

Research output: Contribution to journalLetter

Multiple Myeloma
130-nm albumin-bound paclitaxel

Positron emission tomography (PET) as a predictive measure in patients with metastatic pancreatic cancer and normal CA19-9 levels at baseline

Ramanathan, R. K., Korn, R. L., Chiorean, E. G., Liu, H. & Von Hoff, D. D., Aug 1 2016, In : Annals of Oncology. 27, 8, p. 1647-1648 2 p.

Research output: Contribution to journalLetter

Pancreatic Neoplasms
Positron-Emission Tomography
16 Citations (Scopus)

Tumor-associated macrophages and extracellular matrix metalloproteinase inducer in prognosis of multiple myeloma

Panchabhai, S., Kelemen, K., Ahmann, G., Sebastian, S., Mantei, J. & Fonseca, R., Apr 1 2016, In : Leukemia. 30, 4, p. 951-954 4 p.

Research output: Contribution to journalLetter

CD147 Antigens
Tissue Array Analysis
Neoplasm Staging
Tumor Biomarkers
Stromal Cells
2015
3 Citations (Scopus)
Antineoplastic Combined Chemotherapy Protocols
Melphalan
Thalidomide
Stem Cell Transplantation
Prednisone
30 Citations (Scopus)

The efficacy of ibrutinib in the treatment of Richter syndrome

Tsang, M., Shanafelt, T. D., Call, T. G., Ding, W. D., Chanan Khan, A. A., Leis, J. F., Nowakowski, G. S., Bowen, D., Conte, M., Schwager, S. M., Slager, S. L., Kay, N. E., Hanson, C. A. & Parikh, S. A., 2015, In : Blood. 125, 10, p. 1676-1678 3 p.

Research output: Contribution to journalLetter

Murine-Derived Monoclonal Antibodies
Pyrazoles
Pyrimidines
Vincristine
Protein Kinase Inhibitors
2012

How physicians interpret research funding disclosures [3]

Fonseca, R., Dec 13 2012, In : New England Journal of Medicine. 367, 24, p. 2358-2360 3 p.

Research output: Contribution to journalLetter

Drug Evaluation
Disclosure
Research Design
Physicians
Research
1987
4 Citations (Scopus)

Acquired Factor X Deficiency and Amyloidosis Treated with Melphalan and Prednisone

Levin, M., Chokas, W., Camoriano, J. K., Greipp, P. R., Bowie, E. J. W. & Bayer, G. K., Oct 29 1987, In : New England Journal of Medicine. 317, 18, p. 1155-1156 2 p.

Research output: Contribution to journalLetter

Factor X Deficiency
Thrombin Time
Melphalan
Amyloidosis
Prednisone